Thermo Fisher Scientific

Equities

TMO

US8835561023

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 04:00:02 2024-07-02 pm EDT			5-day change	1st Jan Change
533.9 ^USD	-1.44%		-4.06%	+0.59%

Jul. 02	Evercore ISI Cuts Price Target on Thermo Fisher Scientific to $600 From $615, Maintains Outperform Rating	MT
Jul. 01	Verici Dx hails milestone payment in deal with Thermo Fisher	AN

Declaration of Voting Results by Thermo Fisher Scientific Inc

May 24, 2024 at 04:18 pm EDT

On May 24, 2024, Thermo Fisher Scientific Inc announced that it held its annual general meeting of shareholders on May 22, 2024, and declared voting results. Accordingly, a shareholder proposal to implement simple majority voting submitted by John Chevedden was not approved by the Company shareholders.

Latest news about Thermo Fisher Scientific

Evercore ISI Cuts Price Target on Thermo Fisher Scientific to $600 From $615, Maintains Outperform Rating	Jul. 02	MT
Verici Dx hails milestone payment in deal with Thermo Fisher	Jul. 01	AN
Thermo Fisher Scientific Inc. Expands Clinical Research Laboratory in Kentucky	Jun. 27	CI
Barclays Adjusts Price Target on Thermo Fisher Scientific to $600 From $615	Jun. 27	MT
Labguru Announces New Distribution Partnership with Thermo Fisher Scientific of its Electronic Lab Notebook Module to Help Streamline Life Sciences Research	Jun. 26	CI
Thermo Fisher Scientific Introduces the Only Fully Automated Plasmid Purification System to Help Accelerate Discovery and Development of Therapies	Jun. 25	CI
RBC Trims Price Target on Thermo Fisher Scientific to $660 From $662, Keeps Outperform Rating	Jun. 24	MT
Thermo Fisher Scientific Inc. Expands Clinical Research Laboratory in Wisconsin	Jun. 18	CI
Thermo Fisher Scientific Inc., National University Hospital, Singapore and Mirxes Collaborates to Enhance Access to Advanced Genomic Testing for Early Cancer Detection in Singapore	Jun. 18	CI
Verici Dx plc Announces Successful Transfer of Urine Samples to Thermo Fisher Scientific	Jun. 18	CI
Devyser Diagnostics AB Announces Expanded Commercial Agreement with Thermo Fisher Scientific for Post-Transplant Monitoring NGS Products	Jun. 17	CI
Thermo Fisher Scientific Introduces Thermo Scientific Heracell VIOS 250i AxD CO2 Incubators	Jun. 12	CI
Thermo Fisher Scientific Insider Sold Shares Worth $11,374,358, According to a Recent SEC Filing	Jun. 05	MT
Thermo Fisher Scientific Introduces Innovative Mass Spectrometer to Advance Clinical Research	Jun. 03	CI
Thermo Fisher Scientific Opens New GMP-Certified Ultra-Cold Facility in the EU to Accelerate Advanced Therapies Development	Jun. 03	CI
Thermo Fisher Scientific Updates Chromosomal Microarray Analysis Solutions to Comply with IVDR Regulation	May. 31	CI
Declaration of Voting Results by Thermo Fisher Scientific Inc	May. 24	CI
Thermo Fisher Scientific Keeps Quarterly Dividend of $0.39 a Share, Payable July 15 to Shareholders of Record on June 14	May. 22	MT
Thermo Fisher Scientific Inc. Declares Quarterly Dividend, Payable on July 15, 2024	May. 22	CI
Thermo Fisher Scientific Introduces Array-Based Solution for Extended Blood Type Research to Support Future Advancements Toward Safer Transfusions	May. 15	CI
Transcript : Thermo Fisher Scientific Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 08:00 AM	May. 14
UK Competition Regulator Opens Probe on Thermo Fisher, Olink Merger	May. 10	MT
UK Competition Watchdog Opens Probe on Thermo Fisher Scientific's Acquisition of Olink	May. 10	MT
UK's CMA kicks off probe into Thermo Fisher-Olink deal	May. 10	RE
Bio-Rad Laboratories reiterates 2024 revenue growth outlook; shares slip	May. 07	RE

Chart Thermo Fisher Scientific

Duration

Period

More charts

Company Profile

Thermo Fisher Scientific Inc. specializes in the design, manufacturing and marketing of laboratory and scientific equipments. Net sales (including intragroup) break down by family of products as follows: - laboratory equipments (70%). Moreover, the group proposes chemical products (reagents, solvent, salts, etc.), consumable products (tubes, funnels, vials, etc.), as well as conditioning, warehousing, storage, etc.; - diagnostics equipment and products (15.3%); - scientific analysis equipments (14.7%): analyzer (of water, gas, grounds, etc.), mass spectrometers, molecular spectroscopes, microscopes, manometers, samplers, microbiology equipments, reactive agents, etc. Net sales break down by source of income into products sales (78.5%) and services (21.5%). Net sales break down geographically as follows: North America (53%), Europe (25.7%), Asia-Pacific (18.1%) and others (3.2%).

Sector

Advanced Medical Equipment & Technology

Calendar

2024-07-24 - Q2 2024 Earnings Release

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Thermo Fisher Scientific

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

533.9 USD

Average target price

628.2 USD

Spread / Average Target

+17.66%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
THERMO FISHER SCIENTIFIC	+0.59%	204B
DANAHER CORPORATION	+3.92%	178B
INTUITIVE SURGICAL, INC.	+30.07%	156B
BOSTON SCIENTIFIC CORPORATION	+32.42%	113B
SIEMENS HEALTHINEERS AG	+1.63%	64.26B
EDWARDS LIFESCIENCES CORPORATION	+19.65%	54.98B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-1.86%	47.44B
AGILENT TECHNOLOGIES, INC.	-9.53%	36.7B
GE HEALTHCARE TECHNOLOGIES INC.	-1.28%	34.84B
RESMED, INC.	+10.07%	27.82B

Other Advanced Medical Equipment & Technology